Phase I Study Of The Non-Receptor Kinase Inhibitor Bosutinib In Combination With Pemetrexed In Patients With Selected Metastatic Solid Tumors.
Posted Date: May 15, 2019
- Investigator: John Morris
- Type of Study: Drug
Investigator Initiated UCCI-EXP-16-01
Criteria:
To Be Eligible To Participate In This Study, Study Participants Must Have Biopsy Proven Non-Squamous
Keywords:
Cancer, Ucci-Exp-16-01, Solid Tumor, Phase I, Metastatic Solid Tum
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com